ID: ALA4441529

Max Phase: Preclinical

Molecular Formula: C25H34N8OS

Molecular Weight: 494.67

Molecule Type: Unknown

Representations

Canonical SMILES:  Cc1ccc(NCc2ccnn2-c2nnc(N3CCC(C(=O)N[C@H]4CCCC[C@H]4C)CC3)s2)nc1

Standard InChI:  InChI=1S/C25H34N8OS/c1-17-7-8-22(26-15-17)27-16-20-9-12-28-33(20)25-31-30-24(35-25)32-13-10-19(11-14-32)23(34)29-21-6-4-3-5-18(21)2/h7-9,12,15,18-19,21H,3-6,10-11,13-14,16H2,1-2H3,(H,26,27)(H,29,34)/t18-,21+/m1/s1

Standard InChI Key:  FUGSGMMXUVQDOY-NQIIRXRSSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 494.67

Molecular Weight (Monoisotopic): 494.2576

AlogP: 3.95

#Rotatable Bonds: 7

Polar Surface Area: 100.86

Molecular Species: NEUTRAL

HBA: 9

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 6.96

CX LogP: 3.97

CX LogD: 3.84

Aromatic Rings: 3

Heavy Atoms: 35

QED Weighted: 0.51

Np Likeness Score: -1.87

References

1. Song S, Jiang J, Zhao L, Wang Q, Lu W, Zheng C, Zhang J, Ma H, Tian S, Zheng J, Luo L, Li Y, Yang ZJ, Zhang X..  (2019)  Structural optimization on a virtual screening hit of smoothened receptor.,  172  [PMID:30939349] [10.1016/j.ejmech.2019.03.057]

Source

Source(1):

• Scientific Literature